Eli Lilly (NYSE: LLY) partners with Switzerland-based AC Immune (Nasdaq: ACIU) to research and develop the potential treatment for Alzheimer’s … Continue reading Eli Lilly to collaborate with AC Immune for the treatment of Alzheimer’s disease